respiratori
infect
common
cold
season
worldwid
consequ
consid
trivial
mild
affect
individu
rare
consult
medic
profession
instead
treat
symptomat
medic
droplet
aerosol
transmiss
facilit
rapid
dissemin
numer
individu
amplifi
socioeconom
impact
even
minim
increas
fatal
rate
particularli
among
patient
comorbid
latest
contemporari
outbreak
respiratori
pathogen
name
sever
acut
respiratori
syndrom
coronaviru
respons
coronaviru
diseas
brought
attent
hidden
threat
old
enemi
third
major
coronaviru
outbreak
past
year
substanti
socioeconom
impact
first
centuri
affect
countri
across
contin
except
antarctica
gener
panic
insecur
express
across
sociopolit
econom
tier
dramat
disrupt
daytoday
life
intern
travel
trade
notwithstand
sever
lifestyl
disrupt
depressionassoci
diseas
report
due
extrem
measur
isol
emphas
current
knowledg
regard
coronavirus
short
histori
epidemiolog
diagnosi
pathogenesi
clinic
manifest
well
treatment
prevent
strategi
forward
lesson
inform
futur
strategi
improv
surveil
prevent
recurr
highlight
belong
orthocoronavirina
subfamili
famili
coronavirida
order
nidoviral
compris
four
subtyp
infect
human
gamma
deltacoronavirus
found
anim
zoonot
viru
transmit
anim
human
adapt
human
via
airborn
droplet
aerosol
involv
carrier
anim
speci
human
infect
bat
though
anim
reservoir
extend
cattl
pig
turkey
camel
mice
dog
cat
ferret
mink
first
coronaviru
infect
report
caus
common
cold
sinc
four
subtyp
coronavirus
report
infect
human
two
coronavirus
coronavirus
routin
produc
noncompl
infect
upper
andor
lower
respiratori
tract
mark
key
moment
understand
coronavirusinduc
diseas
emerg
first
lethal
sever
acut
respiratori
syndrom
sar
caus
coronaviru
similarli
origin
sarscov
emerg
guangdong
provinc
china
spread
human
transmiss
chain
infect
least
individu
countri
succumb
patient
novel
previous
observ
human
detect
first
time
patient
saudi
arabia
sinc
new
coronaviru
caus
middl
eastern
respiratori
syndrom
known
merscov
infect
individu
across
countri
led
death
least
individu
novemb
seri
emerg
reemerg
camelid
host
decemb
wuhan
hubei
provinc
china
first
case
report
new
coronaviru
produc
pneumonia
sinc
new
viru
first
name
subsequ
renam
identifi
member
subtyp
spread
rapidli
via
humantohuman
transmiss
time
author
march
case
record
worldwid
across
countri
death
attribut
viru
fig
emerg
virul
strain
coronaviru
past
year
increas
interest
scientist
regard
coronaviru
strain
variabl
distribut
abil
transmit
anim
human
humanstohuman
strain
slightli
differ
distribut
across
sex
age
demograph
attribut
exampl
whilst
affect
male
femal
substanti
ageassoci
mortal
increas
frail
elderli
subject
four
societ
nondisrupt
coronavirus
affect
femal
children
year
contrast
affect
femal
rel
young
peopl
median
age
sar
infect
patient
guangzhou
provinc
china
year
mortal
rate
peopl
year
comparison
mer
coronaviru
frequent
detect
among
male
middleag
adult
age
year
emerg
data
hospit
case
wuhan
hubei
provinc
china
indic
male
middleag
adult
age
group
year
predominantli
affect
preval
peopl
age
year
among
case
chronic
diseas
cardiovascular
cerebrovascular
diseas
endocrin
system
diseas
digest
system
diseas
respiratori
system
diseas
malign
tumor
nervou
system
diseas
likewis
data
itali
indic
median
age
year
middl
age
year
old
elderli
predominantli
male
patient
experienc
mild
sever
diseas
burden
mortal
year
old
case
fatal
ratio
year
old
year
old
whilst
older
popul
demograph
itali
believ
drive
higher
case
fatal
ratio
differ
vs
china
italian
healthcar
system
experienc
increas
requir
intens
care
unit
icu
admiss
case
anecdot
report
frontlin
clinician
princip
affect
region
itali
indic
icu
bed
dedic
patient
admiss
icumechan
ventil
restrict
age
group
higher
likelihood
surviv
note
report
indic
icu
case
involv
individu
age
young
year
age
reader
strongli
advis
consid
care
territoryspecif
divers
case
sever
definit
well
diagnost
triagedefinit
criteria
make
direct
epidemiolog
comparison
one
addit
aspect
complic
case
epidemiolog
oversight
pertain
highli
mutagen
natur
coronavirus
common
across
rna
virus
led
inappropri
compar
evolut
interpret
even
incorrect
assert
mild
sever
aris
separ
strain
compar
genom
sequenc
strain
shown
synonym
mutat
spike
gene
rat
bat
coronavirus
quit
differ
ratio
nucleotid
substitut
amino
acid
substitut
compar
significantli
higher
ratio
addit
numer
concern
engin
bioweapon
hypothes
fed
specul
sequenc
ident
hiv
align
show
present
coronaviru
strain
show
identitysimilar
sequenc
gag
former
also
cellular
receptor
recognit
protein
consid
insert
appear
hypervari
region
protein
short
residu
length
probabl
aros
natur
consequ
articl
describ
similar
recent
withdrawn
public
date
evid
support
manmad
close
resembl
two
coronavirus
trigger
outbreak
recent
decad
sequenc
ident
merscov
ident
three
virus
like
origin
bat
sequenc
ident
recent
sequenc
bat
coronaviru
recov
wild
random
sampl
major
question
regard
coronaviru
epidemiolog
bat
anim
play
central
role
coronaviru
epidemiolog
studi
bat
identifi
virus
origin
speci
potenti
vector
human
infect
addit
bat
live
coloni
present
high
risk
transmit
virus
horizont
intraspeci
contribut
vertic
crossspeci
spread
abil
hypothesi
strongli
favor
data
anoth
high
socioeconom
impact
batderiv
viru
ebola
viru
shown
effici
infect
bat
human
cell
date
remain
favor
hypothesi
index
case
infect
west
african
ebolaviru
diseas
outbreak
addit
evid
bat
human
indirect
transmiss
come
spike
protein
receptor
interact
inde
two
highli
pathogen
strain
coronavirus
sarscov
merscov
identifi
bat
speci
anim
involv
transmiss
human
interest
note
first
highli
pathogen
strain
coronaviru
low
genet
similar
known
coronavirus
bovin
coronaviru
porcin
epidem
diarrhea
viru
recent
three
comparison
studi
made
coronaviru
strain
pangolin
first
februari
compar
sequenc
coronavirus
illeg
traffick
pangolin
show
sequenc
similar
subsequ
paper
februari
report
sequenc
similar
pangolin
coronavirus
respect
howev
strain
caus
human
diseas
also
origin
identifi
bat
therefor
surpris
share
genet
similar
whole
genom
level
coronaviru
isol
chines
bat
speci
anoth
import
question
china
china
thirdlargest
countri
surfac
area
worldwid
popul
countri
vari
land
characterist
divers
climat
rang
support
huge
biodivers
contribut
enabl
transmiss
virus
anim
popul
princip
howev
cohabit
anim
human
close
proxim
gastronom
custom
involv
consumpt
varieti
exot
anim
includ
wild
fauna
bat
increas
chanc
vertic
transmiss
throughout
food
suppli
chain
offici
livebird
market
close
howev
blackmarket
vendor
run
illeg
slaughterhous
crowd
place
poor
ventil
number
speci
hoard
togeth
creat
ideal
condit
spread
viru
airborn
droplet
blood
secret
share
cage
trade
tool
utensil
allow
amplif
vertic
transmiss
risk
preval
culinari
wild
anim
handl
practic
southern
china
causal
link
outbreak
start
market
shenzen
guangdong
china
entri
human
popul
origin
case
present
pneumonia
unknown
origin
two
third
link
huanan
seafood
wholesal
market
also
sold
live
anim
speci
barrier
bridg
also
document
filoviru
diseas
outbreak
africa
wherein
high
risk
infecti
agent
routin
detect
bushmeat
market
associ
human
popul
pcr
immunoprecipit
method
china
human
anim
close
contact
often
cohabit
remain
common
rural
african
area
practic
barrier
wild
environ
eg
tropic
forest
exposur
data
fed
debat
role
socal
herd
immun
natur
exposur
emerg
tropic
perhap
rural
zoonos
noteworthi
compar
risk
document
virus
typic
associ
highli
biodivers
geographi
consumpt
wild
meat
exampl
outbreak
merscov
middl
east
arab
peninsula
specif
shown
involv
local
intern
citi
dweller
previou
exposur
natur
camelid
host
continu
close
contact
rural
popul
fig
direct
impact
individu
health
zoonos
indirect
impact
healthcar
system
evidenc
outbreak
underscor
increasingli
urban
popul
organis
even
among
develop
nation
amplifi
risk
onward
human
transmiss
despit
past
exposur
inde
immun
set
blur
wildhuman
habitat
barrier
genom
coronavirus
contain
gene
structur
protein
envelop
e
membran
nucleocapsid
n
spike
coronaviru
virion
lipid
bilayerenvelop
particl
variabl
size
nm
character
multipl
spikelik
extens
surfac
form
corolla
flower
petal
virion
core
nucleocapsid
icosahedr
symmetri
contain
electrondens
layer
center
clear
genom
nucleic
acid
consist
singlestrand
posit
rna
requir
neg
rna
replic
cycl
intermedi
gener
subgenom
protein
code
rna
well
genom
rna
virion
assembl
core
also
featur
accessori
protein
differ
consider
variou
type
coronavirus
lipid
envelop
featur
trimericallyorganis
type
transmembran
spike
glycoprotein
consist
ectodomain
subunit
protrud
extern
transmembran
anchor
tail
extend
toward
viral
core
cell
attach
involv
subunit
interact
host
cell
surfac
receptor
drive
endocytosi
membran
fusion
involv
subunit
releas
virion
core
cytosol
milieu
glycoprotein
coronavirus
mediat
attach
fusion
entri
host
cell
differ
part
glycoprotein
involv
process
class
viral
membranefus
protein
undergo
structur
rearrang
produc
fusion
viral
cellular
membran
glycoprotein
conform
chang
cathepsin
l
proteolysi
within
endosom
also
involv
pathogenesi
coronaviru
fig
thu
whilst
cleavag
protein
requir
expos
hydrophob
fusion
peptid
seem
receptor
interact
requir
cleavag
occur
histor
immunotherapi
mani
exploratori
small
molecul
treatment
target
hostpathogen
interact
disrupt
infect
howev
experi
across
multipl
viru
strain
indic
monotherapi
ineffici
due
mutat
escap
accessori
protein
play
definit
role
infect
howev
function
yet
fulli
understood
specul
protein
play
import
role
counter
immun
respons
thu
virus
lack
lower
infect
exampl
two
accessori
protein
play
potenti
role
virul
strain
hand
sometim
complet
infecti
particl
assembl
without
spike
protein
indic
accessori
protein
substitut
therefor
potenti
risk
vaccin
target
structur
protein
alon
spike
protein
might
ineffici
drive
evolutionari
escap
viru
either
target
protein
mutat
favour
virion
util
accessori
protein
attach
somewhat
viral
escapeproof
approach
involv
target
receptorbind
domain
rbd
conserv
domain
protein
notabl
respiratori
virus
effici
cross
speci
barrier
eg
influenza
requir
close
monitor
annual
adjust
epitop
target
minim
spread
impact
primari
receptor
use
coronavirus
enter
target
cell
angiotensinconvertingenzym
ii
receptor
although
strain
also
use
altern
receptor
lower
affin
whilst
evid
pre
postpubl
literatur
current
also
util
cell
entri
potenti
attach
mechan
exclud
experiment
data
thereto
produc
likewis
yet
unidentifi
receptor
facilit
coronaviru
cellular
entri
absenc
hepatocyt
enterocyt
particular
also
appear
use
sarscov
receptor
enter
cell
although
spike
protein
vari
sequenc
xu
et
al
suggest
spike
protein
bind
affin
conserv
structur
receptor
bind
domain
ident
would
translat
equal
infect
analysi
proteinprotein
interact
use
bioinformat
show
sar
nucleocapsid
protein
bind
human
cyclophilin
hcypa
bind
demonstr
surfac
plasmon
reson
spr
technolog
model
detect
probabl
bind
site
allow
deduct
import
interact
residu
pair
wan
colleagu
observ
sever
amino
acid
receptorbind
motif
allow
bind
human
even
though
suboptim
strength
recent
studi
demonstr
mutat
spike
protein
enhanc
affin
highli
express
respiratori
tract
particularli
epitheli
cell
bronchi
alveoli
type
ii
cell
trachea
bronchial
serou
gland
well
macrophag
alveolar
monocyt
notabl
express
lung
cell
much
higher
trachea
line
express
profil
viral
genom
load
consist
report
elev
lower
upper
respiratori
tract
lower
respiratori
specimen
addit
less
prone
fals
neg
result
also
diffus
locat
cell
mucos
cell
intestin
endotheli
cell
vein
arteri
includ
heart
cell
epitheli
cell
renal
tubul
epitheli
cell
kidney
immun
cell
cerebr
neuron
cell
may
also
suscept
coronaviru
infect
observ
patient
demis
account
sever
heart
failur
brought
infect
higher
risk
among
patient
previou
cardiovascular
hypertens
diseas
driven
multipl
hypothes
regard
potenti
direct
mechan
viral
action
circulatori
system
thu
express
increas
result
use
drug
ace
inhibitor
angiotensin
ii
typei
receptor
blocker
arb
inde
shown
express
increas
diabet
patient
anoth
high
risk
group
treat
ace
inhibitor
hypertens
patient
treat
arb
express
also
increas
thiazolidinedion
ibuprofen
therefor
categori
patient
risk
infect
propos
higher
yet
whilst
coronaviru
strain
bind
receptor
produc
upper
respiratori
tract
diseas
indic
unknown
factor
apart
presenc
receptor
influenc
suscept
cell
coronaviru
infect
insight
differenti
factor
influenc
coronaviru
strainspecif
outcom
come
recent
data
host
cofactor
mediat
fusion
thu
use
serin
proteas
protein
prime
camostat
mesyl
inhibitor
block
infect
lung
cell
inhibit
substanti
endosom
cystein
proteas
cathepsin
bl
catbl
also
inhibit
eg
result
point
complex
interplay
host
factor
endosom
spike
protein
mediat
virion
fusion
thu
specul
infect
cell
furinmedi
precleavag
site
promot
entri
case
merscov
merscov
howev
except
sar
coronaviru
set
use
hedipeptidyl
peptidas
surfac
antigen
receptor
rel
express
endosom
factor
similarli
activ
protein
across
cell
type
well
altern
receptor
mediat
cellular
attach
requir
urgent
scrutini
understand
cell
type
tropism
crucial
extrapulmonari
reservoir
site
replic
extrapulmonari
reservoir
suggest
ct
scan
show
shadow
interstiti
chang
tissu
separ
lung
requir
molecular
cellular
studi
confirm
direct
involv
viru
replic
oppos
patholog
find
secondari
infect
coronavirus
infect
primari
cell
matur
virion
releas
infect
target
cell
infect
viral
particl
found
sweat
stool
urin
respiratori
secret
patient
coronavirus
viabl
far
document
respiratori
droplet
saliva
mechan
gener
aerosol
faec
excret
environment
contamin
substanti
fomit
present
current
believ
primari
mode
humantohuman
transmiss
day
surfac
deposit
viru
develop
atyp
pneumonia
rapid
respiratori
deterior
failur
determin
coronaviru
infect
associ
increas
level
activ
proinflammatori
chemokin
cytokin
thu
propos
vitamin
play
role
modul
immun
respons
infecti
agent
base
laboratori
find
observ
studi
howev
random
clinic
trial
return
inconclus
often
controversi
result
therefor
suggest
cholecalciferol
elev
dose
might
use
prevent
therapi
infect
pathogeni
coronaviru
infect
import
role
play
amplitud
host
immun
exampl
canon
interferon
level
termin
protein
synthesi
even
induc
cell
death
howev
intens
immun
respons
vari
depend
comorbid
patient
explain
role
evolut
diseas
inde
major
death
occur
among
individu
comorbid
nationwid
studi
china
patient
cancer
howev
patient
liver
transplant
inflammatori
bowel
diseas
patient
diabet
hypertens
death
rate
expect
higher
immunocompromis
patient
howev
establish
date
hand
seem
exacerb
immun
reaction
infect
one
lead
greatest
pulmonari
system
damag
merscov
lower
infect
compar
thu
intens
prolong
exposur
necessari
order
viru
enter
lung
merscov
use
cell
receptor
express
wide
varieti
epitheli
cell
local
alveoli
kidney
liver
small
intestin
prostat
activ
leukocyt
determin
higher
tropism
merscov
compar
coronavirus
genom
sequenc
earli
stage
outbreak
enabl
ultrafast
develop
pointofcar
test
base
rtpcr
new
infect
within
week
discoveri
line
past
predict
rapid
respons
http
date
howev
avail
kit
format
benchtop
real
time
pcr
system
requir
substanti
manual
process
h
minim
data
turnaround
emerg
use
author
eua
use
thesesimilar
assay
hand
numer
regulatorapprov
pointofcar
integr
extractionamplif
system
eg
biofir
genexpert
etc
obtain
march
unaccept
month
outbreak
consequ
despit
tremend
need
mass
screen
isol
infect
case
sampl
process
bottleneck
forc
health
author
govern
worldwid
restrict
test
clinic
complex
hospit
case
convers
experi
countri
earli
outbreak
experi
korea
singapor
hong
kong
taiwan
itali
inde
china
show
mass
test
case
isol
contact
trace
reduc
human
transmiss
even
zero
inde
present
risk
countri
appear
restrict
new
case
introduct
abroad
justifi
measur
seek
halt
intern
travel
diagnost
process
notwithstand
major
drawback
lie
diagnost
sensit
prefer
oppos
avail
sampl
thu
data
chines
centr
diseas
control
prevent
well
clinic
centr
epicent
outbreak
reinforc
world
health
organis
technic
diagnost
guidelin
requir
lower
respiratori
sampl
well
upper
respiratori
sampl
rule
causal
agent
viral
pneumonia
diseas
simplest
upper
respiratori
sampl
present
form
oral
andor
nasal
swab
combin
given
hand
report
nasal
swab
neg
presenc
oral
swab
posit
lower
respiratori
specimen
difficult
obtain
requir
either
intub
patient
tracheal
aspir
anesthesia
bronchoalveolar
lavag
bronchial
brush
notwithstand
risk
injuri
patient
invas
procedur
creat
infecti
aerosol
gener
risk
contraind
suitabl
surrog
sampl
lung
sputum
natur
avail
minim
aerosol
gener
risk
unfortun
chines
experi
suspect
case
gener
sputum
therebi
restrict
test
oral
nasal
swab
howev
report
fals
neg
rate
oral
swab
fals
neg
rate
account
low
analyt
sensit
reach
statist
point
underscor
impact
sampl
process
variabl
beyond
anatom
differ
one
healthcar
profession
swab
techniqu
may
differ
vastli
anoth
emphas
need
standardizingautom
sampl
process
increas
diagnost
test
reliabl
even
respiratori
sampl
signific
addit
complic
factor
limit
understand
sampl
viral
load
across
exposuresymptomaticconvalesc
continuum
onset
shed
dispar
genom
copi
detect
rtpcr
vs
infecti
virion
copi
number
collect
amplifi
wellestablish
issu
around
oper
error
sampl
method
interest
earli
data
suggest
viral
shed
may
inde
start
earli
one
week
ahead
symptom
transmiss
may
peak
day
symptom
data
accept
valid
separ
studi
compound
impact
transmiss
risk
attribut
asymptomat
subclin
individu
emphas
need
aggress
contact
trace
test
even
onto
random
mass
popul
screen
need
arrest
transmiss
anecdot
evid
suggest
singl
town
itali
combin
lockdown
contact
trace
test
elimin
new
case
whilst
transmiss
remain
rampant
elsewher
countri
hand
particular
import
attribut
number
western
govern
serolog
assay
monitor
product
antibodi
respons
pathogen
first
glanc
test
exceedingli
appeal
due
lower
cost
timetoresult
compar
rtqpcr
diagnost
lab
inde
use
autom
point
care
rtqpcr
system
lower
cost
faster
addit
antibodi
test
offer
clear
answer
spread
exposur
may
involv
asymptomat
lowgrad
respiratori
diseas
support
call
herd
immun
howev
evid
multipl
asian
countri
itali
show
transmiss
contain
achiev
achiev
use
rtqpcr
document
infecti
case
antibodi
respons
initi
least
week
onset
symptom
mean
deploy
antibodi
test
mass
screen
enhanc
risk
fals
neg
compar
oronas
swab
rtqpcr
miss
presymptomat
asymptomat
newli
symptomat
case
whilst
research
academ
valu
understand
asymptomat
spread
undisput
magnitud
socioeconom
damag
redirect
resourc
away
confirm
activ
infect
mildli
symptomat
case
asymptomat
contact
onto
exposur
number
like
extend
transmiss
long
beyond
period
week
document
china
korea
month
extend
impact
onto
healthcar
system
furthermor
extens
spread
risk
develop
cycl
infect
socioeconom
damag
reintroduct
new
index
case
within
countri
region
countri
free
diseas
increas
risk
viru
evolut
establish
season
endem
respiratori
diseas
agent
crucial
take
account
immun
coronavirus
appear
shortliv
simpli
know
yet
convalesc
protect
reinfect
long
predomin
symptom
respiratori
natur
associ
fever
diarrhea
clinic
manifest
among
patient
divers
mildmoder
severelif
threaten
symptom
viru
mean
incub
period
day
howev
major
case
symptom
appear
day
sever
case
median
time
appear
symptom
artifici
ventil
day
day
patient
death
clinic
manifest
similar
flulik
symptom
fever
dri
cough
myalgia
dyspnea
headach
sore
throat
sputum
product
rhinorrhea
case
wateri
diarrhea
appear
within
week
first
manifest
elderli
symptom
also
associ
confus
poor
appetit
decreas
gener
wellb
noteworthi
symptomatolog
children
year
mild
mortal
regist
among
children
teenag
asymptomat
case
report
rare
increas
level
creactiv
protein
lymphopenia
thrombocytopenia
increas
level
lactat
dehydrogenas
observ
laboratori
test
infect
manifest
two
differ
stage
firstweek
character
flulik
symptom
improv
even
viral
load
persist
recurr
period
second
week
respiratori
failur
appear
patient
may
requir
mechan
ventil
respiratori
system
main
affect
area
human
bodi
infect
determin
appear
diffus
alveolar
damag
squamou
metaplasia
giantcel
infiltr
increas
macrophag
level
interstitium
alveoli
unlik
middl
east
respiratori
syndrom
coronaviru
merscov
wide
varieti
clinic
manifest
asymptomat
sever
respiratori
symptom
mean
incub
period
day
sever
case
death
occur
within
day
onset
diseas
clinic
manifest
similar
flulik
symptom
gener
myalgia
fever
chill
malais
associ
confus
pulmonari
symptom
cough
short
breath
dyspnea
pneumonia
extrapulmonari
clinic
manifest
includ
abdomin
disord
nausea
diarrhea
vomit
acut
renal
failur
neurolog
complic
sever
diseas
associ
increas
age
individu
comorbid
diabet
mellitu
renal
pulmonari
diseas
death
occur
develop
acut
respiratori
distress
syndrom
ard
multiorgan
failur
septic
shock
neurolog
complic
infect
merscov
associ
vitro
abil
viru
invad
central
nervou
system
although
detect
csf
among
neurolog
manifest
confus
report
seizur
case
sever
neurolog
complic
enceph
stroke
polyneuropathi
acut
dissemin
encephalomyel
guillain
syndrom
bickerstaff
enceph
usual
neurolog
complic
appear
delay
time
point
respiratori
symptom
name
week
onset
clinic
manifest
diseas
underdiagnos
children
rare
affect
laboratori
test
thrombocytopenia
lymphopenia
neutrophilia
leucocytosi
reduc
renal
function
increas
inflammatori
marker
observ
similar
pathogenesi
yet
fulli
elucid
viralmedi
lung
damag
character
diffus
alveolar
damag
viru
determin
multinucl
epitheli
cell
pneumocyt
bronchial
submucos
gland
apart
respiratori
system
viru
also
identifi
epitheli
cell
proxim
renal
tubul
acut
tubular
sclerosi
tubulointerstiti
nephriti
observ
renal
biopsi
collect
person
infect
merscov
latest
high
clinic
burden
coronaviru
present
wide
varieti
clinic
manifest
yet
fulli
character
viru
mean
incub
period
day
day
although
anecdot
report
like
relat
poor
contact
trace
suggest
potenti
day
incub
outsid
hubei
provinc
median
incub
period
estim
day
ci
infect
subject
develop
symptom
within
day
infect
retrospect
studi
patient
confirm
pneumonia
treat
infecti
diseas
hospit
wuhan
china
shown
main
clinic
manifest
flulik
symptom
fever
cough
case
short
breath
case
muscl
ach
case
less
frequent
confus
headach
sore
throat
rhinorrhea
chest
pain
less
patient
extrapulmonari
symptom
diarrhea
nausea
vomit
also
observ
complic
ard
report
case
follow
acut
respiratori
injuri
septic
shock
acut
renal
injuri
ventilatorassoci
pneumonia
death
occur
particip
studi
determin
multipl
organ
failur
main
find
laboratori
test
lymphopenia
sever
diseas
associ
coinfect
smoke
histori
hypertens
age
anoth
retrospect
studi
patient
infect
reveal
pattern
clinic
manifest
fever
cough
muscl
pain
less
frequent
diarrhea
headach
even
heart
palpit
case
lymphopenia
observ
case
associ
normal
decreas
white
blood
cell
count
lung
main
organ
affect
imag
examin
comput
tomographi
xray
lesion
identifi
multipl
lung
lobe
present
patchypunct
groundglass
opac
ggo
patchi
consolid
irregular
solid
nodul
fibrou
stripe
studi
investig
pulmonari
pattern
pneumonia
demonstr
diseas
progress
rapidli
ct
reexamin
day
reveal
signific
chang
lung
structur
singl
ggo
observ
earli
stage
increas
significantli
shortterm
reexamin
also
occur
fibrou
stripe
observ
earli
stage
consolid
shortterm
reexamin
case
irregular
solid
nodul
observ
earli
stage
increas
merg
shortterm
reexamin
shortterm
repeat
imag
scan
carri
patient
pneumonia
monitor
evolut
specif
manag
patient
diseas
rapidli
progress
inde
resolv
peak
lung
abnorm
reach
day
follow
onset
symptom
follow
decreas
symptomatolog
document
one
third
sever
ill
patient
death
occur
coronaviru
produc
acut
myocardi
injuri
damag
cardiovascular
system
gener
degrad
state
alreadi
ill
patient
treatment
type
coronavirus
mainli
support
specif
treatment
discov
date
treatment
apart
support
measur
sever
therapeut
scheme
implement
vari
success
rate
antivir
therapi
ribavirin
proteas
inhibitor
lopinavir
ritonavir
alon
associ
ribavirin
system
corticosteroid
convalesc
plasma
passiv
immunotherapi
apart
convalesc
plasma
none
treatment
exhibit
signific
benefit
compar
sideeffect
produc
merscov
infect
take
exampl
earli
epidem
support
care
primarili
use
instanc
broadspectrum
antibacteri
antivir
ribavirin
alon
combin
antifung
use
prevent
coinfect
opportunist
pathogen
mycophenol
acid
anoth
drug
exhibit
efficaci
monotherapi
small
number
patient
howev
studi
requir
confirm
effect
case
new
pneumonia
treatment
also
focus
support
care
measur
symptomat
treatment
follow
exampl
treatment
administr
system
corticosteroid
attempt
although
exhibit
benefit
case
patient
sever
evolut
immunoglobulin
g
administ
applic
earli
respiratori
support
improv
prognosi
recoveri
patient
korean
man
infect
administr
combin
lopinavirritonavir
day
ill
determin
decreas
viral
load
till
detect
level
question
whether
decreas
viral
load
associ
natur
cours
heal
process
antivir
treatment
current
investig
order
confirm
efficaci
antivir
treatment
efficaci
remdesivir
gilead
scienc
nucleotid
analog
inhibit
vitro
vivo
merscov
bat
cov
strain
capabl
replic
human
airway
epitheli
cell
render
good
choic
test
newli
affect
patient
take
consider
bind
human
order
penetr
human
cell
induc
sever
pneumonia
reninangiotensin
system
acei
angiotensinconvert
enzym
inhibitor
angiotensin
ii
typei
receptor
inhibitor
suggest
modifi
individu
suscept
influenc
virul
howev
studi
need
confirm
mechan
involv
includ
role
high
express
consid
possibl
chang
administr
dosag
antihypertens
drug
thu
far
profession
associ
hypertens
therapi
usa
warn
chang
hypertens
drug
follow
concern
possibl
increas
suscept
http
interest
arisen
also
old
offpat
antimalari
drug
chloroquin
less
toxic
hydroxychloroquin
analog
quinin
deriv
cinchoca
tree
bark
south
america
preliminari
support
observ
potenti
inhibitori
activ
clearli
need
confirm
random
control
trial
also
ongo
trial
use
monoclon
antibodi
one
tocilizumab
antibodi
current
phase
iii
clinic
trial
commerci
name
actemra
produc
roch
sarilumab
drug
use
rheumatoid
arthriti
enter
clinic
trial
infect
accord
regeneron
pharmaceut
sanofi
respect
order
facilit
viru
replic
certain
vivo
condit
ph
valu
temperatur
humid
suffici
oxygen
suppli
ensur
consequ
order
hinder
reproduct
procedur
viru
would
expedi
disturb
environ
viru
interf
temperatur
ph
valu
specul
season
viru
case
hindranc
rapid
spread
character
ambient
temperatur
celsiu
would
observ
unfortun
suptropicalarid
environ
favor
merscov
well
compar
higher
temperatur
israel
egypt
arab
peninsula
subsaharan
africa
compar
hubei
provinc
indic
temperatur
probabl
affect
replic
likewis
ambient
humid
level
thought
impact
aerosol
droplet
suspens
timetravel
distanc
extens
viru
transmiss
seem
affect
onward
transmiss
chain
across
geograph
region
alter
ph
valu
insid
human
bodi
within
toler
level
howev
achiev
intervent
would
suppress
replic
viru
also
may
although
possibl
weak
virucid
effect
ph
valu
chang
neg
impact
health
patient
could
achiev
administ
drug
would
lead
urin
acidosi
endocellular
alkalosi
drug
could
simpl
small
molecul
hydrophob
weak
base
properti
would
accumul
lysosom
cross
plasma
lysosom
membran
diffus
perhap
medicin
may
express
therapeut
prophylact
effect
increas
environment
barrier
effect
viru
attach
earli
endosom
pathway
prevent
spike
proteolysi
requir
capsid
releas
cell
membran
fusion
within
lysosom
line
cathepsin
proteasetarget
therapi
given
success
combin
therapi
strategi
antivir
diseas
center
viru
fusion
andor
replic
promot
endocellular
alkalosi
antivir
drug
therapi
eg
replic
inhibitor
could
amplifi
antivir
effect
therebi
contribut
reduct
treatment
period
although
sinc
world
health
organ
issu
guidelin
prevent
reemerg
new
coronaviru
virul
strain
implement
evid
inadequ
key
recommend
includ
avail
earli
detect
infect
individu
prevent
spread
emerg
reemerg
infect
particularli
prevent
intern
spread
develop
conting
plan
countri
manag
detect
coronaviru
individu
risk
exist
local
prepar
global
assist
nation
risk
assess
updat
new
discoveri
assist
countri
effort
improv
protect
infect
assess
avail
necessari
resourc
case
outbreak
support
intern
scientif
collabor
sar
studi
unfortun
strategi
could
prevent
current
outbreak
year
medic
scientif
government
structur
demonstr
adequ
prepar
effect
contain
highli
pathogen
virus
main
measur
taken
prevent
dissemin
pathogen
gener
popul
associ
infect
control
measur
healthcar
facil
commun
contact
trace
quarantin
isol
suspect
infect
along
educ
popul
proven
essenti
prevent
commun
transmiss
virus
develop
nation
west
african
democrat
republ
congo
ebola
viru
outbreak
develop
nation
eg
hong
kong
south
korea
sar
mer
outbreak
practic
nation
lack
local
implement
demonstr
effect
measur
learn
sinc
outbreak
due
scientif
chauvin
healthcar
standard
east
west
popul
anthropolog
africa
europ
term
commun
strategi
behaviour
inde
local
vs
intern
experi
eg
uk
itali
emerg
threat
lament
go
forward
identif
natur
reservoir
intermedi
host
exist
futur
risk
identifi
random
sampl
monitor
becom
essenti
prevent
futur
zoonot
viru
outbreak
unfortun
alarm
rais
repeatedli
past
two
decad
minim
heed
perhap
damag
brought
onto
global
economi
healthcar
system
transform
field
tropic
emerg
diseas
good
exampl
posit
action
action
current
team
develop
vaccin
infect
interest
larg
spur
unpreced
success
rapid
develop
ebolaviru
vaccin
west
african
outbreak
vaccin
base
viral
rna
deriv
exampl
includ
innovio
moderna
usa
well
curevac
germani
anoth
team
imperi
colleg
london
rna
dna
vaccin
advantag
quick
develop
high
likelihood
safeti
though
rna
vaccin
therapeut
current
enjoy
regulatori
approv
institut
pasteur
franc
work
tradit
vaccin
base
sar
vaccin
cansino
biolog
develop
recombin
coronaviru
vaccin
incorpor
adenoviru
type
vector
date
clinic
trial
initi
moderna
therapeut
cansino
biolog
trial
shortli
anticip
uk
european
countri
sober
note
howev
despit
ampl
amount
research
perform
coronavirus
past
year
particularli
follow
outbreak
vaccin
unfortun
yet
avail
either
mer
although
potenti
vaccin
reach
far
phase
clinic
trial
strategi
use
vaccin
elicit
neutralizingantibodi
protein
tcell
respons
seem
jointli
requir
convalesc
rather
simpli
neutral
antibodi
titer
quest
protect
immun
coronaviru
nascent
virolog
offer
plethora
high
socioeconom
impact
high
preval
rna
virus
decad
vaccin
research
yet
deliv
success
guangdong
region
china
consid
highrisk
area
coronaviru
outbreak
epidem
nevertheless
although
larg
amount
research
effort
made
worldwid
prevent
outbreak
coronaviru
outbreak
occur
unfortun
healthcar
system
local
nation
intern
overcom
two
major
coronaviru
outbreak
evid
clear
highli
aggress
measur
necessari
break
transmiss
chain
region
risk
practic
countri
global
time
author
unfortun
specif
prevent
strategi
new
coronaviru
pandem
statu
restrict
global
commun
two
option
effect
measur
immedi
prevent
respiratori
infect
predict
measur
consequ
ambit
herd
vaccinederiv
immun
nonspecif
time
futur
hope
third
signific
outbreak
suffici
experi
gain
joint
effort
worldwid
health
author
need
extinguish
current
epidem
trust
experi
reemphas
need
prevent
readi
studi
limit
transmiss
anim
virus
human
mitig
aris
futur
